Relative Value

SKTO latest financial reports are more than 9 years old.
SKTO doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of SKTO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SKTO Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

SKTO Competitors Multiples
SK3 Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
SK3 Group Inc
OTC:SKTO
362 USD 0 0 0 0
US
CVS Health Corp
NYSE:CVS
96.8B USD 0.2 54.8 14 14
US
Cigna Group
XMUN:CGN
67.3B EUR 0.3 13.3 7.8 9.9
US
Cigna Corp
NYSE:CI
70.4B USD 0.3 11.8 0 0
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.4B EUR 1.2 20.9 9.8 14.6
DE
Fresenius Medical Care AG
XMUN:FME
23.3B EUR 1.2 23.8 9.1 16.9
US
Quest Diagnostics Inc
NYSE:DGX
22B USD 2 22.3 12.2 16.6
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 1.6 25.1 12 17.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.2B EUR 0.6 11.5 5.4 10.1
US
Guardant Health Inc
NASDAQ:GH
11.2B USD 11.4 -26.8 -29.4 -26.7
US
DaVita Inc
NYSE:DVA
10.3B USD 0.8 13.8 7.2 9.7
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett